广东省乙肝表面抗原阳性母亲所生婴儿接种后血清学检测完成率的影响因素与趋势(2021-2023年)
本研究基于广东省2021年1月1日至2023年12月31日乙肝表面抗原阳性孕妇及其新生儿的病例记录,分析接种后血清学检测(PVST)完成率趋势及影响因素。共纳入159,629对母婴,PVST完成率在出生体重<2000g婴儿中从74.44%升至82.44%,≥2000g婴儿中从81.96%升至88.01%;7-9月龄完成PVST的比例大幅上升。较高出生体重、较高母亲年龄、孕期抗病毒治疗、较高母亲教育水平及婴儿HBV感染高风险与PVST完成率正相关。
要点
- 2021至2023年,出生体重<2000g婴儿PVST完成率从74.44%升至82.44%,≥2000g婴儿从81.96%升至88.01%。
- 7-9月龄完成PVST的比例在<2000g婴儿中从14.52%升至44.04%,≥2000g婴儿中从31.99%升至51.91%。
- 较高出生体重、较高母亲年龄、孕期抗病毒治疗、较高母亲教育水平及婴儿HBV感染高风险与PVST完成率正相关。
核心结论
- 2021至2023年HBV暴露婴儿PVST完成率显著改善,7-9月龄完成PVST的比例大幅增加,提示PVST依从性取得进展,并强调需针对性干预以进一步提高高风险人群的依从性。
研究设计与样本
- 基于广东省2021年1月1日至2023年12月31日HBsAg阳性孕妇及其新生儿病例记录的真实世界数据分析,共纳入159,629名HBsAg阳性孕妇及其新生儿。
- 采用Cochran-Armitage检验分析2021至2023年按出生体重分层的HBV暴露新生儿PVST完成率趋势及完成PVST的婴儿年龄分布,并采用多因素logistic回归分析影响因素。
主要发现
- 出生体重<2000g婴儿PVST完成率从2021年的74.44%上升至2023年的82.44%,出生体重≥2000g婴儿从81.96%上升至88.01%。
- 7-9月龄完成PVST的比例在出生体重<2000g婴儿中从14.52%上升至44.04%,在出生体重≥2000g婴儿中从31.99%上升至51.91%。
- 对PVST完成率有正向影响的因素包括较高出生体重、较高母亲年龄、孕期接受抗病毒治疗、较高母亲教育水平及婴儿为HBV感染高风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aims to assess the trends and influencing factors in post-vaccination serologic testing (PVST) completion rates among infants born to hepatitis B surface antigen (HBsAg)-positive mothers using real-world data, providing insights to guide future PVST strategy implementation. METHODS: Data were obtained from the case records of HBsAg-positive pregnant women and their newborns in Guangdong Province from January 1, 2021, to December 31, 2023. The Cochran-Armitage test was used to analyze trends in PVST completion rates and the age distribution of infants completing PVST, among HBV-exposed neonates, stratified by birth weight, from 2021 to 2023. Multivariable logistic regression analysis was conducted to identify factors influencing PVST completion rates. RESULTS: Our PVST study analyzed data from 159,629 HBsAg-positive pregnant women and their newborns from 2021 to 2023. PVST completion rate increased from 74.44 % to 82.44 % in infants weighing <2000 g and from 81.96 % to 88.01 % in infants weighing ≥2000 g. A greater number of infants completed PVST at the 7-9 months of age, with proportions rising from 14.52 % to 44.04 % among infants weighing <2000 g and from 31.99 % to 51.91 % among those weighing ≥2000 g. Factors that positively influenced PVST completion rates included higher birth weight, older maternal age, receipt of antiviral treatment during pregnancy, higher maternal education level, infant at high risk for HBV infection. CONCLUSION: This study highlights showing significant improvements in PVST completion rates among HBV-exposed infants from 2021 to 2023. Additionally, the proportion of infants completing PVST at 7-9 months of age increased substantially during this period. These findings highlight the progress made in improving PVST adherence and underscore the importance of targeted interventions to further enhance compliance among at-risk populations.
引用
- Gao S, Cai M, Su M, et al. Influencing factors and trends in post-vaccination serologic testing completion rates among infants born to HBsAg-positive mothers in Guangdong Province, 2021-2023. Vaccine. 2025. PMID: 40749350. doi:10.1016/j.vaccine.2025.127565
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。